2026-527062-72-00RecruitingPhase 1
A multicentre, single-arm, open-label, non-randomised pilot clinical trial to assess the dose-dependent effect of tirzepatide on gastric emptying in adult patients with type 1 diabetes
Source: EU CTIS (euclinicaltrials.eu) · Last updated 22 Sept 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- First submitted
- 12 Jun 2026
- Start date
- 27 Oct 2026
- Lead sponsor
- Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal
- Diseases
- Type 1 diabetes
- EU CT number
- 2026-527062-72-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 12
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario Ramón y Cajal | Madrid | Spain | Recruiting |
| Hospital Universitario Y Politecnico La Fe | Valencia | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.